| Dr Gregory Lynn Jovanelly, DMD | |
|
1921 Main St, Aliquippa, PA 15001-2927 | |
| (724) 378-1000 | |
| (724) 378-1004 |
| Full Name | Dr Gregory Lynn Jovanelly |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 1921 Main St, Aliquippa, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851517262 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | DS027327L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory Lynn Jovanelly, DMD 1921 Main St, Aliquippa, PA 15001-2927 Ph: (724) 378-1000 | Dr Gregory Lynn Jovanelly, DMD 1921 Main St, Aliquippa, PA 15001-2927 Ph: (724) 378-1000 |
News Archive
Neurocrine Biosciences, Inc. announced today that they have established a worldwide collaboration with Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of Type II diabetes and other indications. The companies will work jointly to identify and advance candidates into pre-clinical development. Boehringer Ingelheim is responsible for the global development and commercialization of potential GPR119 agonist products.
Analysis from business intelligence provider GBI Research - Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - states that the global market value for T1DM treatment will rise from $4.2 billion in 2014 to $7.1 billion by 2021, at a robust Compound Annual Growth Rate (CAGR) of 7.9%.
The growing asthma & allergy friendly(TM) Certification Program announced today that it has developed and adopted a certification standard and testing protocol for Non-Disinfecting Hard Surface Spray Cleaning Products. The asthma & allergy friendly(TM) Certification Program - administered by the Asthma and Allergy Foundation of America (AAFA) in partnership with the international research organization, Allergy Standards Limited (ASL) - is an independent, non-exclusive certification program created to scientifically test and identify consumer products that are more suitable for people with asthma and allergies.
Merrimack Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted MM-398 orphan drug status for the treatment of pancreatic cancer.
One year ago, on September 28, 2008, then-Candidate Barack Obama used the world stage provided by the annual meeting of the Clinton Global Initiative to promise that, if elected, he would work to create a Global Fund for Education.
› Verified 5 days ago
Dr. Todd Mendenhall, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1921 Main St, Aliquippa, PA 15001 Phone: 724-378-1000 | |
Dr. James Vito Barbuto, DMD Dentist Medicare: Medicare Enrolled Practice Location: 2496 Brodhead Road, Ste D, Aliquippa, PA 15001 Phone: 724-375-2243 Fax: 724-857-0434 | |
Emily Catharine Dorer, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 2704 Brodhead Rd, Aliquippa, PA 15001 Phone: 724-378-2422 | |
Dr. Timothy A Ungarean Sr., D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: 3153 Brodhead Rd, Suite A, Aliquippa, PA 15001 Phone: 724-857-1010 Fax: 724-857-1012 | |
Dr. Kurt H Dorer, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 2704 Brodhead Rd., Aliquippa, PA 15001 Phone: 724-378-2422 | |
Dr. Robert John Suder, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2093 Brodhead Rd, Aliquippa, PA 15001 Phone: 724-375-2660 | |
Jennifer Jean Unis-sullivan, D.M.D Dentist Medicare: Not Enrolled in Medicare Practice Location: 2072 Brodhead Rd, Aliquippa, PA 15001 Phone: 724-378-9502 Fax: 724-375-1930 |